Anti-FGL1/ HFREP1/ HP-041 functional antibody

Anti-FGL1/ HFREP1/ HP-041 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FGL1/FGL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0926-Ab-1/ GM-Tg-hg-SE0926-Ab-2Anti-Human FGL1 monoclonal antibodyHuman
GM-Tg-rg-SE0926-Ab-1/ GM-Tg-rg-SE0926-Ab-2Anti-Rat FGL1 monoclonal antibodyRat
GM-Tg-mg-SE0926-Ab-1/ GM-Tg-mg-SE0926-Ab-2Anti-Mouse FGL1 monoclonal antibodyMouse
GM-Tg-cynog-SE0926-Ab-1/ GM-Tg-cynog-SE0926-Ab-2Anti-Cynomolgus/ Rhesus macaque FGL1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0926-Ab-1/ GM-Tg-felg-SE0926-Ab-2Anti-Feline FGL1 monoclonal antibodyFeline
GM-Tg-cang-SE0926-Ab-1/ GM-Tg-cang-SE0926-Ab-2Anti-Canine FGL1 monoclonal antibodyCanine
GM-Tg-bovg-SE0926-Ab-1/ GM-Tg-bovg-SE0926-Ab-2Anti-Bovine FGL1 monoclonal antibodyBovine
GM-Tg-equg-SE0926-Ab-1/ GM-Tg-equg-SE0926-Ab-2Anti-Equine FGL1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0926-Ab-1/ GM-Tg-hg-SE0926-Ab-2; GM-Tg-rg-SE0926-Ab-1/ GM-Tg-rg-SE0926-Ab-2;
GM-Tg-mg-SE0926-Ab-1/ GM-Tg-mg-SE0926-Ab-2; GM-Tg-cynog-SE0926-Ab-1/ GM-Tg-cynog-SE0926-Ab-2;
GM-Tg-felg-SE0926-Ab-1/ GM-Tg-felg-SE0926-Ab-2; GM-Tg-cang-SE0926-Ab-1/ GM-Tg-cang-SE0926-Ab-2;
GM-Tg-bovg-SE0926-Ab-1/ GM-Tg-bovg-SE0926-Ab-2; GM-Tg-equg-SE0926-Ab-1/ GM-Tg-equg-SE0926-Ab-2
Products NameAnti-FGL1 monoclonal antibody
Formatmab
Target NameFGL1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FGL1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0926-Ag-1Recombinant multi-species FGL1/ HFREP1/ HP-041 protein


    Target information

    Target IDGM-SE0926
    Target NameFGL1
    Gene ID2267,234199,246186,710903,475617,101082746,508090,100054096
    Gene Symbol and SynonymsFGL1,Frep1,HFREP1,HP-041,HPS,LFIRE-1,LFIRE1,Mfire1
    Uniprot AccessionQ08830,Q5M8C6,Q3SZZ7
    Uniprot Entry NameFGL1_HUMAN,FGL1_RAT,FGL1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000104760
    Target ClassificationN/A

    The target: FGL1, gene name: FGL1, also named as HFREP1, HP-041, LFIRE-1, LFIRE1. Fibrinogen-like 1 is a member of the fibrinogen family. This protein is homologous to the carboxy terminus of the fibrinogen beta- and gamma- subunits which contains the four conserved cysteines of fibrinogens and fibrinogen related proteins. However, this protein lacks the platelet-binding site, cross-linking region and a thrombin-sensitive site which are necessary for fibrin clot formation. This protein may play a role in the development of hepatocellular carcinomas. Four alternatively spliced transcript variants encoding the same protein exist for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.